Efficacy and safety of a low-dose nivolumab regimen (240 mg) as neoadjuvant immunochemotherapy in Chinese patients with resectable non-small cell lung cancer: a prospective single-arm, exploratory study
Juntao Zou(First Affiliated Hospital of Jiangxi Medical College), Ying Wu(First Affiliated Hospital of Jiangxi Medical College), Shaoyun Nie(First Affiliated Hospital of Jiangxi Medical College), Yan Lin(Sichuan University), Zhuchen Yu(First Affiliated Hospital of Jiangxi Medical College), Yating Ai(Hubei University of Chinese Medicine)
Cited by 0
Related Papers
NADP+-IDH Mutations Promote Hypersuccinylation that Impairs Mitochondria Respiration and Induces Apoptosis Resistance
|Molecular Cell|2015|247
Synergistic interfacial engineering of a S-scheme ZnO/In2S3 photocatalyst with S−O covalent bonds: A dual-functional advancement for tetracycline hydrochloride degradation and H2 evolution
|Applied Catalysis B: Environmental|2024|154
Systematic assessment of emerging contaminants elimination using an S-scheme Mn0.5Cd0.5S/In2S3 photocatalyst: Degradation pathways, toxicity evaluation and mechanistic analysis
|CHINESE JOURNAL OF CATALYSIS (CHINESE VERSION)|2025|34
Design dopamine-modified polypropylene fibers towards removal of heavy metal ions from water
|AIP Advances|2017|16
Prediction of spleen-kidney deficiency syndrome in the elderly with mild cognitive impairment：An integrative Chinese and Western medicine approach
|Lishizhen medicine and materia medica research|2025|0